Park Soo-ah

Park Soo-ah

Ask VT AI
View News Summary
  • Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise on expanded insurer coverage for new drug Yeztugo.
  • Jaguars weigh versatile rookie Travis Hunter's impact on both offense and defense as they aim to return to the playoffs.
  • Intel CEO faces resignation calls over alleged China ties, raising national security concerns.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise on expanded insurer coverage for new drug Yeztugo.
  • Jaguars weigh versatile rookie Travis Hunter's impact on both offense and defense as they aim to return to the playoffs.
  • Intel CEO faces resignation calls over alleged China ties, raising national security concerns.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Park Soo-ah